Literature DB >> 20130881

Pattern and outcome of vascular involvement of Omani patients with Behcet's disease.

Juma K Alkaabi1, Anil Pathare.   

Abstract

The objective of the study is to study the pattern, frequency and outcome of vascular events in Omani patients with Behcet's disease (BD). Forty BD patients were recruited. Clinical data parameters were recorded, including age at onset, disease duration, current disease activity, and the vascular manifestations of the disease (current and past events). Disease activity was assessed by ESR, CRP and also clinically. For venous and arterial thrombotic events, imaging studies, such as Doppler ultrasonography, angiography, MRI, CT, and echocardiography were performed. Nine patients had vascular events (23%). The mean age of these patients at diagnosis of the vascular event was 24 years (range 15-37) and the mean disease duration at onset of the vascular event was 3.8 years (range 3-5); this was significant when compared with patients without thrombosis (P=0.001, Mann-Whitney test). In these patients with vascular involvement, two patients (22%) had venous lesions, three (33%) patients had arterial lesions and four patients (44%) had mixed lesions. Two patients (22%) had pulmonary artery aneurysm (PAA) and concomitant intracardiac thrombus, and further one patient also had PAA. Immunosuppressive therapy resulted in the resolution of PAA and intracardiac thrombous. In conclusion, the frequency of vascular complications of BD in our patients is similar to those reported around the world. We found younger male patients with short disease duration are at a greater risk of developing thrombosis. Medical treatment with immunosuppressive therapy without anticoagulation seems successful in treating PAA and intracardiac thrombus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130881     DOI: 10.1007/s00296-010-1363-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  17 in total

Review 1.  Intracardiac thrombus in Behçet's disease: a systematic review.

Authors:  N Mogulkoc; M I Burgess; P W Bishop
Journal:  Chest       Date:  2000-08       Impact factor: 9.410

2.  Treatment and visual prognosis in Behçet's disease.

Authors:  D Benezra; E Cohen
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

3.  Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data.

Authors:  S Lakhanpal; K Tani; J T Lie; K Katoh; Y Ishigatsubo; T Ohokubo
Journal:  Hum Pathol       Date:  1985-08       Impact factor: 3.466

4.  Recognition of the diverse cardiovascular manifestation in Behcet's disease.

Authors:  D G James; A Thomson
Journal:  Am Heart J       Date:  1982-03       Impact factor: 4.749

5.  Thrombosis in Behçet's disease: a retrospective survey from a single UK centre.

Authors:  P R Ames; A Steuer; A Pap; A M Denman
Journal:  Rheumatology (Oxford)       Date:  2001-06       Impact factor: 7.580

6.  Behçet's disease in Saudi Arabia.

Authors:  A N al-Dalaan; S R al Balaa; K el Ramahi; Z al-Kawi; S Bohlega; S Bahabri; M A al Janadi
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

7.  Venous lesions in Behçet's disease.

Authors:  K Sağdiç; Z G Ozer; D Saba; M Türe; M Cengiz
Journal:  Eur J Vasc Endovasc Surg       Date:  1996-05       Impact factor: 7.069

8.  Arterial manifestations of Behçet disease.

Authors:  J H Park; M C Han; M A Bettmann
Journal:  AJR Am J Roentgenol       Date:  1984-10       Impact factor: 3.959

9.  Treatment of venous thrombosis associated with Behcet's disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation.

Authors:  Joong Kyong Ahn; You Sun Lee; Chan Hong Jeon; Eun-Mi Koh; Hoon-Suk Cha
Journal:  Clin Rheumatol       Date:  2007-07-17       Impact factor: 2.980

10.  The ten-year mortality in Behçet's syndrome.

Authors:  H Yazici; G Başaran; V Hamuryudan; N Hizli; S Yurdakul; C Mat; Y Tüzün; Y Ozyazgan; I Dimitriyadis
Journal:  Br J Rheumatol       Date:  1996-02
View more
  8 in total

1.  Peripheral arterial disease in patients with Behçet's disease.

Authors:  Ilknur Balta; Sevket Balta; Sait Demirkol; Ozlem Ekiz
Journal:  Rheumatol Int       Date:  2013-03-28       Impact factor: 2.631

2.  Peripheral arterial involvement in Behcet's disease: an analysis of the results from a Korean referral center.

Authors:  Shin-Seok Yang; Keun-Myoung Park; Yang Jin Park; Young-Wook Kim; Young Soo Do; Hong Suk Park; Kwang Bo Park; Dong-Ik Kim
Journal:  Rheumatol Int       Date:  2013-02-16       Impact factor: 2.631

3.  Analysis of 27 cases of large vascular lesions in 161 cases of Behcet's disease: clinical manifestations and treatment outcome.

Authors:  Shengguang Li
Journal:  Clin Rheumatol       Date:  2014-01-15       Impact factor: 2.980

4.  Haemostatic Parameters in Patients with Behçet's Disease.

Authors:  Juma K Alkaabi; David Gravell; Hamood Al-Haddabi; Anil Pathare
Journal:  Sultan Qaboos Univ Med J       Date:  2014-04-07

5.  Is Immunosuppressive and Thrombolytic Therapy Really Effective in a Patient With Intracardiac Thrombosis and Pulmonary Artery Aneurysm due to Behçet's Disease?

Authors:  Nükhet Aladağ Çiftdemir; Selman Gökalp; Tuba Eren
Journal:  Arch Rheumatol       Date:  2019-05-22       Impact factor: 1.472

Review 6.  Left ventricular intracardiac thrombus in a patient with Behçet disease successfully treated with immunosuppressive agents without anticoagulation: a case report and review of the literature.

Authors:  Tatiana Lisitsyna; Zemfira Alekberova; Pavel Ovcharov; Alexander Volkov; Julia Korsakova; Evgeni Nasonov
Journal:  Rheumatol Int       Date:  2015-06-09       Impact factor: 2.631

7.  Use of contrast-enhanced computed tomographic imaging to diagnose and evaluate Behçet's disease with vascular complications.

Authors:  Lin Qi; Jianfei Cai; Dingbiao Mao; Ming Wang; Xiaojun Ge; Weilan Wu; Xiu Jin; Cheng Li; Yanqing Hua; Ming Li
Journal:  Exp Ther Med       Date:  2019-10-08       Impact factor: 2.447

8.  Behçet's Disease and Intracardiac Thrombosis: A Report of Three Cases.

Authors:  Nurşen Düzgün; Orhan Küçükşahin; Kayhan Çetin Atasoy; Canan Togay Işıkay; Demet Menekşe Gerede; Ayşe Erden; Seda Kaynak Sahap; Muhammed Arif Ibiş; Aşkın Ateş
Journal:  Case Rep Rheumatol       Date:  2013-07-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.